MiNK Therapeutics (INKT) Insider Trading & Ownership → Rich Dad Poor Dad Author Shocks Millions With 2024 Crash Warning (From American Hartford Gold Group) (Ad) Free INKT Stock Alerts $0.92 -0.01 (-1.08%) (As of 09:35 AM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media MiNK Therapeutics (NASDAQ:INKT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.81%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$334,378.80Number OfInsiders Selling(Last 12 Months)0 Get INKT Insider Trade Alerts Want to know when executives and insiders are buying or selling MiNK Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address INKT Insider Buying and Selling by Quarter Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. MiNK Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/16/2023Agenus IncMajor ShareholderBuy429$1.10$471.90 10/12/2023Agenus IncMajor ShareholderBuy3,173$1.10$3,490.30 10/4/2023Agenus IncMajor ShareholderBuy15,001$1.09$16,351.09 8/28/2023Agenus IncMajor ShareholderBuy12,808$1.45$18,571.60 8/24/2023Agenus IncMajor ShareholderBuy170,244$1.54$262,175.76 5/10/2023Agenus IncMajor ShareholderBuy22,065$1.51$33,318.15 (Data available from 1/1/2013 forward) INKT Insider Trading Activity - Frequently Asked Questions Who is on MiNK Therapeutics's Insider Roster? The list of insiders at MiNK Therapeutics includes Agenus Inc, Garo H Armen, and Ulf Wiinberg. Learn more on insiders at INKT. What percentage of MiNK Therapeutics stock is owned by insiders? 17.81% of MiNK Therapeutics stock is owned by insiders. Learn more on INKT's insider holdings. Which MiNK Therapeutics insiders have been buying company stock? The following insiders have purchased INKT shares in the last 24 months: Agenus Inc ($568,552.92), Garo H Armen ($95,000.00), and Ulf Wiinberg ($4,440.87). How much insider buying is happening at MiNK Therapeutics? Insiders have purchased a total of 555,948 INKT shares in the last 24 months for a total of $667,993.79 bought. Which MiNK Therapeutics insiders have been selling company stock? The following insider sold INKT shares in the last 24 months: Garo H Armen ($95,000.00). How much insider selling is happening at MiNK Therapeutics? Insiders have sold a total of 100,000 MiNK Therapeutics shares in the last 24 months for a total of $95,000.00 sold. More Insider Trading Tools from MarketBeat Related Companies: Surrozen Insider Buying NKGen Biotech Insider Buying Protara Therapeutics Insider Buying IN8bio Insider Buying Cortexyme Insider Buying SAB Biotherapeutics Insider Buying Pluri Insider Buying Dyadic International Insider Buying Cyclo Therapeutics Insider Buying Brainstorm Cell Therapeutics Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:INKT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryObama’s Forever Term [exposed]Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
